Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors

Trial ID or NCT#

NCT01965002

Status

not recruiting iconNOT RECRUITING

Purpose

The goal of this project is to evaluate the safety and preliminary efficacy of ExAblate magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) surgery in the treatment of soft tissue tumors of the extremities.

Official Title

A Feasibility Study to Evaluate the Safety and Effectiveness of ExAblate Magnetic Resonance Imaging Guided High Intensity Focused Ultrasound Treatment of Soft Tissue Tumors of the Extremities

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

Investigator(s)

Pejman Ghanouni
Pejman Ghanouni
Radiologist
Professor of Radiology (Body MRI) and, by courtesy, of Neurosurgery, of Obstetrics and Gynecology and of Urology
Raffi S Avedian
Raffi S Avedian
Orthopaedic surgical oncologist, Sarcoma specialist, Musculoskeletal tumors surgeon
Associate Professor of Orthopaedic Surgery

Contact us to find out if this trial is right for you.

Contact

ccto-office@stanford.edu
650-498-7061